(Q44034165)

29 November 2017

title

Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma (English)

1 reference

29 November 2017

1 reference

3

1 reference

29 November 2017

11

Domenico Ribatti

1 reference

29 November 2017

Annunziata De Luisi

1

1 reference

29 November 2017

Laura Binetti

2

1 reference

29 November 2017

Simona Ruggieri

4

1 reference

29 November 2017

Simona Berardi

5

1 reference

29 November 2017

Ivana Catacchio

6

1 reference

29 November 2017

Vito Racanelli

7

1 reference

29 November 2017

Vincenzo Pavone

8

1 reference

29 November 2017

Bernardo Rossini

9

1 reference

29 November 2017

Angelo Vacca

10

1 reference

29 November 2017

language of work or name

1 reference

24 July 2013

1 reference

29 November 2017

1 reference

29 November 2017

volume

16

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

963-973

1 reference

https://scigraph.springernature.com/pub.10.1007/s10456-013-9369-2

29 November 2017

exact match

0 references

cites work

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

The history of the angiogenic switch concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Bone marrow angiogenesis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Angiogenic effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Macrophages as novel target cells for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Endothelial cells in the bone marrow of patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

The gelatin sponge-chorioallantoic membrane assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Placenta growth factor activates monocytes and correlates with sickle cell disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Epo is involved in angiogenesis in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

A novel role for erythropoietin during fibrin-induced wound-healing response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Does erythropoietin accelerate malignant transformation in multiple myeloma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin enhances immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

Erythropoietin in cancer: a dilemma in risk therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-013-9369-2

10.1007/S10456-013-9369-2

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference